An investigation of human beta-defensins and cathelicidin expression in patients with pterygium
Göster/ Aç
Tarih
2017Yazar
Karadag, RemziBayram, Nurettin
Oguztuzun, Serpil
Bayramlar, Huseyin
Bozer, Busra
Simsek, Gulcin
Rapuano, Christopher J.
Üst veri
Tüm öğe kaydını gösterKünye
Karadag, R., Bayram, N., Oguztuzun, S., Bayramlar, H., Bozer, B., Simsek, G., & Rapuano, C. J. (2017). An investigation of human beta-defensins and cathelicidin expression in patients with pterygium. Arquivos brasileiros de oftalmologia, 80(5), 277–280.Özet
Purpose: To investigate human beta-defensins (HBDs) and cathelicidin LL-37 (LL-37) expressions in patients with pterygium. Methods: In this retrospective consecutive case series, 26 pterygium specimens and 15 normal conjunctival specimens of 15 control subjects were in-vestigated. Expressions of HBD-1, HBD-2, HBD-3, and LL-37 were assessed using immunohistochemical staining. A brown color in the cytoplasm and/or nuclei of epithelial cells indicated positive staining for HBDs and LL-37. For each antibody, the intensity of the reaction (negative [-], weak [1+], moderate [2+], or strong [3+]) was determined to describe the immunoreactions. Results: The median age was 52 years in both groups. There were no significant differences in age and sex between the groups (p=0.583, p=0.355, respectively). Of the 26 pterygium specimens, 15 (57.7%) (14 weak, 1 moderate staining) showed HBD-2 expression, which was not observed in any of the control specimens. One (3.8%) pterygium and one (6.7%) control specimen demonstrated weak staining for HBD-3. HBD-2 expression was significantly higher in the pterygium specimens than in the controls (p=0.002). None of the tissue specimens had positive staining for HBD-1 or LL-37 in either group (both; p=1.00). Conclusions: HBD-2 expression was higher in pterygium specimens than in the controls. HBD-2 expression that might be stimulated by inflammatory cytokines may be related to inflammation and fibrovascular proliferation and may play a role in pterygium pathogenesis.